Wang et al. showed experimental evidence of miR-21 inhibition triggered the overexpression of Pten and Ptpn14, which was a result of suppressed intrahepatic cholangiocarcinoma cell proliferation and growth [47]. The gene discussed is PTEN; the disease is intrahepatic cholangiocarcinoma.